Aktie SANDUPHQ6 SANDU PHARMACEUTICALS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Sandu Pharmaceuticals Limited

Aktien

SANDUPHQ6

INE751D01014

SANDUPHQ6

Markt geschlossen - Bombay S.E.
Andere Börsenplätze
 09:00:42 18.05.2024 		% 5 Tage % 1. Jan.
62.7 INR 0.00% Intraday Chart für Sandu Pharmaceuticals Limited +6.92% -7.93%
30.03. Sandu Pharmaceuticals Limited kündigt Änderungen in der Geschäftsführung an CI
14.02. Sandu Pharmaceuticals Limited meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 31. Dezember 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Sandu Pharmaceuticals Limited Appoints Shri Vijay Kajrekar as Chief Financial Officer
Sandu Pharmaceuticals Limited Announces Executive Changes
Sandu Pharmaceuticals Board Mulls CFO Appointment
Sandu Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Sandu Pharmaceuticals CFO to Step Down in December
Sandu Pharmaceuticals Limited Announces CFO Changes
Sandu Pharmaceuticals' Consolidated Net Profit Slips in Fiscal Q2
Sandu Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Sandu Pharmaceuticals Limited Approves Change in Directorate
Sandu Pharmaceuticals Shuts Goa, India Plant for Renovation
Sandu Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2023
Sandu Pharmaceuticals Limited Recommends Dividend for the Financial Year Ended 31St March 2023
Sandu Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Sandu Pharmaceuticals Expands Partnership with Vietnam's Bach Ma Van Xuan; Shares Jump 3%
Sandu Pharmaceuticals Limited Enters into Memorandum of Understanding with Bach Ma Van Xuan Pharmaceuticals
Sandu Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Sandu Pharmaceuticals Limited Approves Dividend for the Financial Year Ended March 31, 2022
Sandu Pharmaceuticals Limited Recommends Dividend for the Financial Year Ended 31 March 2022
Sandu Pharmaceuticals Forms New Subsidiary for Phytoceuticals Products
Sandu Pharmaceuticals Limited Incorporates Subsidiary
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. SANDUPHQ6 Aktie
  4. Nachrichten Sandu Pharmaceuticals Limited
  5. Andere Sprachen